Profile
International Journal of Gynecology & Clinical Practices Volume 6 (2019), Article ID 6:IJGCP-151, 6 pages
http://dx.doi.org/10.15344/2394-4986/2019/151
Original Article
Special Issue: Gynecology & Surgical Oncology
Prevalence of Human Papilloma Virus (HPV) in Women between 35 and 65 Years Old with Inappropriate Screening of Cervical Cancer in La Rioja

Elizalde CR*, Hernández J, Puente MJ and Oteo JA

Hospital San Pedro, Logroño, Spain
Catalina Renata Elizalde Martínez Peñuela, calle piqueras 98, 26006 San Pedro´s Hospital. Logroño, La Rioja; E-mail: renata.elizalde.martinezpenuela@navarra.es
25 October 2019; 19 December 2019; 20 December 2019
Elizalde CR, Hernández J, Puente MJ, Oteo JA (2019) Prevalence of Human Papilloma Virus (HPV) in Women between 35 and 65 Years Old with Inappropriate Screening of Cervical Cancer in La Rioja. Int J Gynecol Clin Pract 6: 151. https://doi.org/10.15344/2394-4986/2019/151

References

  1. Centers for Disease Control and Prevention (2004) Prevention of Genital Human Papillomavirus Infection. Report to Congress.
  2. Ferlay J, Bray F, Pisani P, Parkin DM (2005) GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide. IARC cancer. Lyon: IARC Press.
  3. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S, et al. (2007) Human papillomavirus and cervical cancer. Lancet 370: 890-907. View
  4. Joura EA, Lösch A, Haider-Angeler MG, Breitenecker G, Leodolter S (2000) Trends in vulvar neoplasia. Increasing incidence of vulvar intraepithelial neoplasia and squamous cell carcinoma of the vulva in young women. J Reprod Med 45: 613-615. View
  5. International Agency for Research on Cancer (2005) Handbook of cancer prevention. Cervix cancer screening. Lyon: IARC.
  6. Van der Aa MA, Pukkala E, Coebergh JW, Anttila A, Siesling S, et al. (2008) Mass screening programmes and trends in cervical cancer in Finland and the Netherlands. Int J Cancer 122: 1854-1858. View
  7. Blade A1, Cararach M, Castro M, Catalá-López F, Pérez-Escolano I, et al. (2010) Clinical management of abnormal cytology test results and costs associated with the prevention of cervical cancer in Spain. J Low Genit Tract Dis 14: 311-318. View
  8. De Sanjosé S, Díaz M, Castellsague X, Clifford G, Bruni L, et al. (2007) Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 7: 453-459. View
  9. Bruni L, Barrionuevo-Rosas L, Albero G, Aldea M, Serrano B, et aI. (2016) ICO Information Centre on HPV and Cancer (HPV Infor- mation Centre). Human Papillomavirus and Related Diseases in the World. Summary Report.
  10. Trigo-Daporta M, García-Campello M, Pérez-Ríos M, Santiago-Pé- rez MI, Fernandez-Rodriguez E, et al. (2014) High-risk human papillomavirus in Galicia, Spain: Prevalence and evaluation of the sample representativeness. Scand J Infect Dis 46: 737-744. View
  11. Bernal M, Burillo I, Mayordomo JI, Moros M, Benito R, et al. (2008) Human papillomavirus (HPV) infection and intraepithelial neoplasia and invasive cancer of the uterine cervix: A case-control study in Zaragoza, Spain. Infect Agent Cancer 3: 8. View
  12. Martín P, Kilany L, García D, López-García AM, Martín MJ, et al. (2011) Human papillomavirus genotype distribution in Madrid and correlation with cytological data. BMC Infectious Diseases 11: 316. View
  13. Delgado D, Marín JM, de Diego J, Guerra S, González B, et al. (2012) Human papillomavirus (HPV) genotype distribution in women with abnormal cervical cytology in the Basque Country, Spain. EnfermInfecc Microbiol Clin 30: 230-235. View
  14. del Amo J, González C, Losana J, Clavo P, Muñoz L, et al. (2005) Influence of age and geographical origin in the prevalence of high risk human papillomavirus in migrant female sex workers in Spain. Sex Transm Infect 81: 79-84. View
  15. García S, Domínguez-Gil M, Gayete J, Rojo S, Muñoz JL, et al. (2017) Prevalencia de virus del papiloma humano en mujeres españolas de un programa de cribado poblacional. Revista Española de Quimioterapia 30: 177-182. View
  16. Myers ER, McCrory DC, Nanda K, Bastian L, Matchar DB, et al. (2000) Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. Am J Epidemiol 151: 1158-1171. View
  17. Castellsagué X, Iftner T, Roura E, Vidart JA, Kjaer SK, et al. (2012) Prevalence and genotype distribution of human papillomavirus infection of the cervix in Spain: The CLEOPATRE study. J Med Virol 84: 947-956. View
  18. Roura E, Iftner T, Vidart JA, Kjaer SK, Bosch FX, et al. (2012) Predictors of human papillomavirus infection in women undergoing routine cervical cancer screening in Spain: the CLEOPATRE study. BMC InfectDis 12: 3-6. View
  19. Ammatuna P, Giovannelli L, Matranga D, Ciriminna S, Perino A, et al. (2008) Prevalence of genital human papilloma virus infection and genotypes among young women in Sicily, South Italy. Cancer Epidemiol Biomarkers Prev 17: 2002-2006. View
  20. Vaccarella S , Franceschi S , Snijders PJ , Herrero R , Meijer CJ , et al. (2010) Concurrent infection with multiple human papillomavirus types: pooled analysis of the IARC HPV Prevalence Surveys. Cancer Epidemiol Biomarkers Prev 19: 503-510. View
  21. Rebolj M, Preisler S, Ejegod DM, Rygaard C, Lynge E, et al. (2014) Disagreement between Human Papillomavirus Assays: An Unexpected Challenge for the Choice of an Assay in Primary Cervical Screening. PLoS ONE 9: e86835. View